Floating Button

Cristiano Ronaldo puts US$7.5 mil into Herbalife health platform

Joe Easton & Subrat Patnaik / Bloomberg
Joe Easton & Subrat Patnaik / Bloomberg • 2 min read
Cristiano Ronaldo puts US$7.5 mil into Herbalife health platform
Ronaldo has spent US$7.5 million on a 10% stake in HBL Pro2col Software LLC.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

(Feb 19): Cristiano Ronaldo is putting a small part of his personal fortune into health and wellness technology by investing in a digital platform owned by Herbalife.

The 41-year-old Portuguese footballer, who has played in Saudi Arabia since 2023, spent US$7.5 million ($9.5 million) on a 10% stake in HBL Pro2col Software LLC, Herbalife said alongside fourth-quarter results.

“Investing in Pro2col felt like a natural evolution — in addition to representing Herbalife, this is about helping shape and grow a platform that can truly change how people engage with their health and wellness,” Ronaldo said, according to a statement from Herbalife. Bloomberg News has reached out to Ronaldo for further comment.

Pro2Col’s platform uses an individual’s unique data to build a wellness plan specific to them, with daily habits and smart nutrition tracking, the company says.

Ronaldo — who became the first footballer to join the Bloomberg Billionaire’s Index in 2025, with an estimated net worth of US$1.4 billion — has been a paid endorser of Herbalife since 2013.

Herbalife surged 15% in pre-market trading. Mizuho Securities analyst John Baumgartner sees the Ronaldo news as “enhancing brand potential.” On the results, Baumgartner said the firm has seen a further revenue recovery, ahead of consensus.

See also: Macquarie-led group to buy Qube Holdings for US$8.3 bil

The rally follows long-term underperformance for the shares. Over the past five years, the stock has declined by about two thirds.

Back in 2012, billionaire investor Bill Ackman placed a US$1 billion bet against the company, triggering a high-profile battle with Carl Icahn, who took a large long position.

In 2016, the Federal Trade Commission required Herbalife to pay US$200 million and restructure its business to settle US claims that it deceived customers. Ackman exited his position in 2018, though he claimed vindication when the shares plunged 43% to a 14-year low in February 2024.

Uploaded by Magessan Varatharaja

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.